Ironwood Pharmaceuticals (IRWD) Depreciation and Depletion (2018 - 2026)

Ironwood Pharmaceuticals has disclosed Depreciation and Depletion across 9 years of filings, most recently posting $443000.0 for Q1 2026.

• Depreciation and Depletion for Q1 2026 came in at $443000.0, down 7.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (down 6.68% YoY), and the FY2025 annual result was $1.9 million, down 6.46% from the prior year.
• Depreciation and Depletion came in at $443000.0 for Q1 2026 at Ironwood Pharmaceuticals, down from $460000.0 in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $513000.0 in Q1 2024 to a low of $270000.0 in Q2 2023.
• The 5-year median for Depreciation and Depletion is $467000.0 (2025), against an average of $431058.8.
• Across the five-year window, Depreciation and Depletion retreated 25.0% in 2023 and soared 87.41% in 2024, its largest moves.
• Ironwood Pharmaceuticals' Depreciation and Depletion stood at $340000.0 in 2022, then soared by 50.59% to $512000.0 in 2023, then fell by 5.27% to $485000.0 in 2024, then declined by 5.15% to $460000.0 in 2025, then fell by 3.7% to $443000.0 in 2026.
• The last three Depreciation and Depletion figures came in at $443000.0 (Q1 2026), $460000.0 (Q4 2025), and $475000.0 (Q3 2025), per Business Quant data.